Sanara Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Sanara Medtech
SMTI Stock  USD 20.55  1.50  6.80%   
Sanara Medtech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sanara Medtech's valuation are provided below:
Gross Profit
94 M
Profit Margin
(0.37)
Market Capitalization
183.6 M
Enterprise Value Revenue
2.2525
Revenue
101.9 M
We have found one hundred twenty available fundamental trend indicators for Sanara Medtech, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Sanara Medtech current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 188.5 M. Enterprise Value is estimated to decrease to about 192.2 M

Sanara Medtech Total Revenue

104.66 Million

Check Sanara Medtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanara Medtech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.9 M, Interest Expense of 3.8 M or Total Revenue of 104.7 M, as well as many indicators such as Price To Sales Ratio of 3.55, Dividend Yield of 0.0324 or PTB Ratio of 6.76. Sanara financial statements analysis is a perfect complement when working with Sanara Medtech Valuation or Volatility modules.
  
Build AI portfolio with Sanara Stock
Check out the analysis of Sanara Medtech Correlation against competitors.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

Sanara Medtech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets106.4 M101.3 M29.8 M
Slightly volatile
Short and Long Term Debt Total39 M37.1 M8.1 M
Slightly volatile
Other Current Liabilities16.2 M15.4 M5.2 M
Slightly volatile
Total Current Liabilities18.5 M17.6 M6.8 M
Slightly volatile
Property Plant And Equipment Net2.3 M2.2 M957.2 K
Slightly volatile
Accounts Payable1.8 M1.7 M689.1 K
Slightly volatile
Cash19.2 M18.3 M5.6 M
Slightly volatile
Non Current Assets Total66.2 M63 M17.9 M
Slightly volatile
Cash And Short Term Investments19.2 M18.3 M5.6 M
Slightly volatile
Net Receivables16.4 M15.6 M4.3 M
Slightly volatile
Common Stock Shares Outstanding10.2 M9.8 M4.1 M
Slightly volatile
Liabilities And Stockholders Equity106.4 M101.3 M29.8 M
Slightly volatile
Non Current Liabilities Total40.9 M39 M8.7 M
Slightly volatile
Other Current Assets1.4 M1.3 M468.8 K
Slightly volatile
Total Liabilities59.4 M56.6 M15.2 M
Slightly volatile
Total Current Assets40.2 M38.3 M11.8 M
Slightly volatile
Short Term Debt306.7 K322.8 K711.9 K
Slightly volatile
Common Stock7.5 K7.9 K58.9 K
Slightly volatile
Inventory3.3 M3.2 M1.5 M
Slightly volatile
Common Stock Total Equity9.1 K9.5 K55.9 K
Slightly volatile
Property Plant And Equipment Gross3 M2.9 M1.2 M
Slightly volatile
Current Deferred Revenue2.5 M2.4 M1.3 M
Slightly volatile
Intangible Assets49.5 M47.2 M13.5 M
Slightly volatile
Long Term Debt37.1 M35.3 M9 M
Slightly volatile
Short and Long Term Debt725.8 K667.4 K572.8 K
Slightly volatile
Property Plant Equipment1.7 M1.6 M702.1 K
Slightly volatile
Other Liabilities7.2 M6.9 M2.3 M
Slightly volatile
Long Term Investments10 M9.5 M3.5 M
Slightly volatile
Capital Stock7.5 K7.9 K797.4 K
Very volatile
Short Term Investments880 K990 K1.1 M
Slightly volatile
Capital Surpluse43.1 M75 M30.8 M
Slightly volatile

Sanara Medtech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense3.8 M3.6 M952.5 K
Slightly volatile
Total Revenue104.7 M99.7 M28.5 M
Slightly volatile
Gross Profit94.8 M90.3 M25.3 M
Slightly volatile
Other Operating Expenses112.8 M107.4 M32.6 M
Slightly volatile
Cost Of Revenue9.8 M9.4 M3.2 M
Slightly volatile
Total Operating Expenses102.9 M98 M29.3 M
Slightly volatile
Selling General Administrative92.4 M88 M26.5 M
Slightly volatile
Reconciled Depreciation5.9 M5.7 M1.4 M
Slightly volatile
Research Development6.9 M6.6 M1.6 M
Slightly volatile
Non Recurring24 K27 K29.5 K
Slightly volatile

Sanara Medtech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow6.2 M5.9 M3.2 M
Slightly volatile
End Period Cash Flow19.2 M18.3 M5.6 M
Slightly volatile
Dividends Paid240.3 K253 K769.5 K
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.553.748.3506
Slightly volatile
Dividend Yield0.03240.03080.0222
Slightly volatile
Days Sales Outstanding73.9265.6362.5164
Slightly volatile
Average Payables1.7 M1.6 M697 K
Slightly volatile
Stock Based Compensation To Revenue0.05590.05890.29
Slightly volatile
EV To Sales3.763.968.6269
Slightly volatile
Inventory Turnover2.713.41.9541
Slightly volatile
Days Of Inventory On Hand135142333
Slightly volatile
Payables Turnover11.576.2414.085
Slightly volatile
Sales General And Administrative To Revenue1.751.151.406
Slightly volatile
Average Inventory3.5 M3.4 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.03660.05920.0206
Slightly volatile
Capex To Revenue0.00290.0030.0233
Very volatile
Cash Per Share1.771.680.891
Slightly volatile
Days Payables Outstanding73.4777.3486.7093
Very volatile
Intangibles To Total Assets0.340.580.3112
Pretty Stable
Current Ratio2.061.961.4802
Slightly volatile
Receivables Turnover6.997.368.4577
Pretty Stable
Capex Per Share0.02950.03110.0969
Pretty Stable
Average Receivables299.1 K450.4 K439.9 K
Pretty Stable
Revenue Per Share9.659.194.9438
Slightly volatile
Interest Debt Per Share3.384.82.1154
Very volatile
Debt To Assets0.40.420.6017
Slightly volatile
Graham Number0.620.710.7708
Slightly volatile
Operating Cycle386208264
Slightly volatile
Days Of Payables Outstanding73.4777.3486.7093
Very volatile
Effective Tax Rate0.220.380.5965
Slightly volatile
Quick Ratio1.891.81.2162
Slightly volatile
Cash Ratio0.980.930.7511
Slightly volatile
Cash Conversion Cycle107102163
Very volatile
Days Of Inventory Outstanding135142333
Slightly volatile
Days Of Sales Outstanding73.9265.6362.5164
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio10.069.582.737
Slightly volatile
Fixed Asset Turnover10153.0157.501
Very volatile
Debt Ratio0.40.420.6017
Slightly volatile
Price Sales Ratio3.553.748.3506
Slightly volatile
Asset Turnover0.980.891.4123
Slightly volatile
Gross Profit Margin0.860.820.7609
Slightly volatile

Sanara Medtech Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap188.5 M253.5 M139.6 M
Slightly volatile
Enterprise Value192.2 M268.3 M140.2 M
Slightly volatile

Sanara Fundamental Market Drivers

Forward Price Earnings33.8983
Cash And Short Term Investments15.9 M

Sanara Upcoming Events

18th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
18th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sanara Medtech Financial Statements

Investors use fundamental indicators, such as Sanara Medtech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sanara Medtech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue2.4 M2.5 M
Total Revenue99.7 M104.7 M
Cost Of Revenue9.4 M9.8 M
Stock Based Compensation To Revenue 0.06  0.06 
Sales General And Administrative To Revenue 1.15  1.75 
Research And Ddevelopement To Revenue 0.06  0.04 
Revenue Per Share 9.19  9.65 
Ebit Per Revenue(0.07)(0.07)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:
How To Invest In Sanara
Details
Is Sanara Stock a good investment?
Details
What is Sanara Medtech's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Sanara Medtech Correlation against competitors.
For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is there potential for Health Care Equipment & Supplies market expansion? Will Sanara introduce new products? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.72)
Revenue Per Share
11.859
Quarterly Revenue Growth
0.215
Return On Assets
0.0113
Return On Equity
(0.28)
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sanara Medtech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY